Gilead Sciences (GILD)

EBITDA

-$9.31B

Quarterly · Period ending: · USD

GILD logo

GILD EBITDA

Latest reported-$9.31B
GILD Quarterly EBITDA ($100.00K → -$9.31B)
High-resolution chart · PNG

GILD ebitda history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Gilead Sciences EBITDA — Quarterly (USD)
Period endingEBITDA (USD)
-9,309,000,000
3,040,000,000
3,020,000,000
4,583,000,000
3,374,000,000
2,605,000,000
3,109,000,000
1,884,000,000
2,984,000,000
-3,542,000,000
2,593,000,000
3,234,000,000
2,499,000,000
2,170,000,000
2,785,000,000
3,186,000,000
2,270,000,000
611,000,000
1,532,000,000
4,211,000,000
2,592,000,000
2,994,000,000
2,508,000,000
1,416,000,000
-2,384,000,000
2,593,000,000
2,494,000,000
-904,000,000
3,006,000,000
2,963,000,000
1,631,000,000
3,286,000,000
2,708,000,000
2,680,000,000
2,820,000,000
4,259,000,000
4,682,000,000
4,172,000,000
4,477,000,000
4,817,000,000
4,910,000,000
5,015,000,000
5,945,000,000
5,915,000,000
5,924,000,000
5,661,000,000
4,635,347,000
3,743,000,000
4,674,000,000
3,266,000,000
1,313,892,000
1,222,880,000
1,226,784,000
1,096,261,000
1,182,000,000
1,111,405,000
1,125,429,000
832,268,000
967,266,000
1,091,085,000
1,103,588,000
996,715,000
917,662,000
1,063,719,000
1,069,713,000
1,236,892,000
1,140,847,000
965,474,000
826,619,000
851,622,000
795,091,000
702,351,000
657,025,000
720,381,000
523,950,000
562,562,000
557,459,000
571,815,000
496,991,000
424,792,000
377,905,000
382,895,000
373,902,000
259,582,000
283,933,000
229,614,000
171,727,000
169,888,000
164,209,000
150,273,000
94,134,000
84,325,000
112,723,000
59,601,000
36,728,000
39,665,000
22,627,000
-3,585,000
-21,079,000
-32,275,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.